The objective of this study was to explore the application of circulating GDF-15 as a biomarker of disease severity and prognosis as well as to monitor response to deoxynucleosides treatment in patients with TK2 deficiency, and compare it with FGF-21. This evidence concerns the gene TK2 and hyperinsulinemic hypoglycemia, familial, 4.